Brief: GoodRx Reports Third Quarter 2023 Results
Nov 9 (Reuters) - Goodrx Holdings Inc GDRX.O :
* GOODRX REPORTS THIRD QUARTER 2023 RESULTS
* EXPECT OUR 2024 ADJUSTED EBITDA MARGIN TO MEET OR EXCEED
4Q23
* SEES FY REVENUE $742 MILLION-$748 MILLION
* FY2023 REVENUE VIEW $755.0 MILLION -- LSEG IBES DATA
Source text for Eikon: ID:nBwcbMLD5a
Further company coverage: GDRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million